Do You Need to Taper Off Estrogen Therapy?
No, you do not need to taper off estrogen therapy—approximately 75% of women can stop abruptly without major difficulty, and there is no evidence that tapering reduces withdrawal symptoms compared to abrupt discontinuation. 1, 2
Evidence on Tapering vs. Abrupt Discontinuation
Among women who successfully stopped hormone therapy, 71% discontinued abruptly while only 29% tapered, and there was no difference in the incidence of troublesome withdrawal symptoms or successful quitting between these two approaches. 2
Current guidelines recommend using the lowest effective dose for the shortest time necessary, with annual reassessment and attempts at discontinuation once symptoms are controlled. 3, 1
What to Expect When Stopping
Approximately 74–75% of women who attempt to stop hormone therapy are able to do so successfully without resuming treatment. 1, 2
The remaining 25–26% of women resume hormone therapy, primarily due to the development of troublesome vasomotor symptoms (hot flashes, night sweats) after discontinuation. 1, 2
The major predictor of resuming hormone therapy is the development of troublesome withdrawal symptoms, with an odds ratio of 8.8 (95% CI 4.9–16.0). 2
Who Has More Difficulty Stopping?
Women who started hormone therapy specifically for treatment of menopausal symptoms are more likely to experience troublesome symptoms when stopping, compared to those who started for other reasons such as osteoporosis prevention. 1
Women with a hysterectomy who used hormone therapy for 10 or more years and started mainly for reasons other than health promotion had a 44% failure rate when attempting to stop, compared to 9% in women with none of these characteristics. 2
Practical Approach to Discontinuation
First attempt: Stop abruptly and monitor for withdrawal symptoms over 2–4 weeks, as this approach is equally effective as tapering and allows faster assessment of whether you can tolerate discontinuation. 2
If severe withdrawal symptoms develop: You have three options:
Important Timing Considerations
Vasomotor symptoms typically improve or resolve spontaneously within a few months to a few years of onset in the majority of women, suggesting most women should be able to discontinue within a few years of starting treatment. 1
For women who started hormone therapy before age 60 or within 10 years of menopause, the risk-benefit profile becomes less favorable after age 60 or more than 10 years post-menopause, making discontinuation attempts particularly important at these milestones. 3
Critical Pitfall to Avoid
Do not assume tapering is necessary or superior—the evidence shows no benefit of tapering over abrupt discontinuation for preventing withdrawal symptoms, and many clinicians recommend tapering based on tradition rather than data. 1, 2
For women who cannot tolerate even a slow taper and have severe recurrent symptoms, the value of symptom relief likely outweighs any increased risks due to continued hormone therapy use at the lowest effective dose. 1